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Paget disease of bone is characterized by focal increases of the bone-remodeling process. It is the second most
common metabolic bone disease after osteoporosis. Genetic factors play a major role in the etiology of Paget disease
of bone, and two loci have been mapped for the disorder: PDB1 and PDB2. The gene(s) causing the typical form
of the disorder remains to be characterized. To decipher the molecular basis of Paget disease of bone, we performed
genetic linkage analysis in 24 large French Canadian families (479 individuals) in which the disorder was segregating
as an autosomal dominant trait. After exclusion of PDB2, a genomewide scan was performed on the three most
informative family nuclei. LOD scores 11.0 were observed at seven locations. The 24 families were then used to
detect strong evidence for linkage to chromosome 5q35-qter. Under heterogeneity, a maximum LOD score of 8.58
was obtained at D5S2073, at . The same characteristic haplotype was carried by all patients in eight families,vp .1
suggesting a founder effect. A recombination event in a key family confined the disease region within a 6-cM
interval between D5S469 and the telomere. The 16 other families, with very low conditional probability of linkage
to 5q35-qter, were further used, to map a second locus at 5q31. Under heterogeneity, a maximum LOD score of
3.70 was detected at D5S500 with . Recombination events refined the 5q31 region within 12.2 cM, betweenvp .00
D5S642 and D5S1972. These observations demonstrate the mapping of two novel loci for Paget disease of bone
and provide further evidence for genetic heterogeneity of this highly prevalent disorder. It is proposed that the
5q35-qter and 5q31 loci be named “PDB3” and “PDB4,” respectively.
Introduction
Paget disease of bone (MIM 167250) is a localized mon-
ostotic or polyostotic progressive metabolic bone dis-
order. The disease is characterized by an increased re-
modeling process in which abnormal bone resorption
remains coupled to new osteoblastic bone formation.
Paget disease of bone usually appears at 140 years of
age (Klein and Norman 1995) and mainly affects the
axial skeleton. Approximately 5% of pagetic patients
present symptoms requiring treatment (Kanis 1998). The
most frequent complaints are bone pain, enlargement,
and deformities at the pagetic site (Kanis 1998). Other
manifestations of the disease include increased suscep-
tibility to fractures, deafness, and neurological compli-
cations, as well as an increased susceptibility to osteo-
sarcomas (Hamdy 1995). In Western countries, Paget
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disease of bone is the second most common metabolic
bone disorder after osteoporosis. In the United States,
the disorder has an estimated frequency of 1%–3% in
the population 140 years of age and of 8%–10% in
those 180 years of age (Siris and Canfield 1990).
The primary defect of Paget disease seems to reside
in the osteoclast, but, despite numerous studies, the
pathological basis of the disorder remains unknown.
Within the pagetic lesion, osteoclasts are large, multi-
nucleated, and overactive. Pagetic cells also contain
paramyxovirus-like inclusions (Mills and Singer 1976;
Gherardi et al. 1980; Rebel et al. 1980b; Harvey et al.
1982; Howatson and Fornasier 1982). Detection of an-
tigens and/or nucleic acid sequences of paramyxoviruses
in symptomatic bone (Rebel et al. 1980a; Mills et al.
1984; Gordon et al. 1991; Reddy et al. 1995, 1996,
1999; Mee et al. 1998) have indicated that chronic viral
infection may cause the disease (Harvey et al. 1982;
Cartwright et al. 1993; Abe et al. 1995). Other studies
have questioned this hypothesis, since they were un-
able to confirm these observations (Ralston et al. 1991;
Birch et al. 1994; Helfrich et al. 2000; Ooi et al. 2000).
Further experimentation is thus required in order to
assess the involvement of paramyxoviral infection in the
pathogenesis of Paget disease of bone.
Laurin et al.: Mapping of Two PDB Loci at 5q35-qter and 5q31 529
Table 1
Clinical Features of Representative Patients Selected for Genomewide Scan
PATIENT
AGE
(years)
STATUSa
TOTAL SERUM
ALKALINE
PHOSPHATASE
(#ULN)b
RADIOLOGICAL
FEATURES
NO. OF BONE
SITES AFFECTED
TOTAL
PAGETIC
BONEc
(%)
When
Studied
At
Diagnosis
DD-003 77 … N Normal Normal 0 0
DD-004 76 48  25.2 Paget 31 37
DD-019 73 70  .5 Paget 2 16
DD-021 71 67  .7 Paget 1 3
DD-033 53 49  .5 Paget 4 5
TH-019 55 43  1.0 Paget 3 7
TH-102 64 60  1.6 Paget 15 53
TH-111 83 58  20.3 Paget 14 64
TH-143 52 46  11.8 Paget 26 31
LF-010 57 54  1.0 Paget 6 20
LF-019 80 … N Normal Normal 0 0
LF-045 78 68  3.7 Paget 7 36
LF-074 74 46  4.4 Paget 16 64
a As described in the Patients, Material, and Methods section. N p normal;  p Paget disease of bone.
b ULN p upper limit of normal range, as determined by each clinical laboratory.
c Calculated by use of Re´nier et al.’s (1995) index.
On the other hand, there is compelling evidence that
genetic factors play a major role in the etiology of Paget
disease of bone. The disease is most common in western
Europe (Detheridge et al. 1983), North America (Rosen-
baum and Hanson 1969; Guyer and Chamberlain 1980),
Australia (Barker 1984), and New Zealand (Reasbeck et
al. 1983), with the highest prevalence occurring in the
United Kingdom, particularly in Lancashire (prevalence
16.3%) (Barker et al. 1980). Familial risk for Paget dis-
ease of bone has been evaluated by several authors. Sofaer
et al. observed a 10-fold–increased prevalence among the
parents and siblings of patients, compared to spouses of
patients (Sofaer et al. 1983). In the United States, Siris
et al. further reported that 12% of pagetic patients had
a first-degree relative affected with Paget disease of bone
and calculated that first-degree relatives had a sevenfold-
increased risk of developing the disease (Siris et al. 1991).
In Spain, Mirales-Piga et al. observed that 40% of their
index cases had at least one first-degree relative affected
with Paget disease of bone (Morales-Piga et al. 1995).
Familial clustering of Paget disease of bone also has been
frequently documented (Sofaer et al. 1983; Siris et al.
1991; Morales-Piga et al. 1995; Haslam et al. 1998;
Hocking et al. 2000). In the kindreds investigated thus
far, Paget disease of bone has appeared to be transmitted
with an autosomal dominant mode of inheritance with
incomplete penetrance. Since the majority of patients
with Paget disease of bone are asymptomatic, the inci-
dence of a familial association is likely to be underre-
ported. Even if multifactorial inheritance cannot be ex-
cluded, the late onset of the disease may account for the
incomplete penetrance of the disorder in pedigrees with
autosomal dominant inheritance.
Suggestive evidence was first reported for linkage be-
tween Paget disease of bone and the HLA locus at 6p
(Fotino et al. 1977; Tilyard et al. 1982). This potential
locus was named “PDB1” (MIM 167250). However,
further studies did not confirm linkage to this site
(Breanndan Moore and Hoffman 1988; Nance et al.
2000; Good et al. 2001), suggesting that the role of the
HLA locus may be of minor importance in the etiology
of Paget disease of bone.
A rare bone disorder, familial expansile osteolysis
(FEO [MIM 174810]), which also displays bone lesions
containing paramyxoviral-like nuclear inclusions, has
been mapped to chromosome 18q21-q22 (Hughes et al.
1994). Using a candidate-locus approach and a large
pagetic family, Cody et al. (1997) reported evidence for
linkage between Paget disease of bone and the same 18q
region, with a LOD score of 3.40 at D18S42. This locus
was called “PDB2” (MIM 602080). This later study
proposed that the gene(s) responsible for FEO and Paget
disease of bone were either closely linked or allelic var-
iants of the same mutant gene. Subsequently, Haslam
et al. (1998) confirmed linkage to 18q in five pagetic
families and observed genetic heterogeneity in three
other kindreds. More recent studies confirmed genetic
heterogeneity of the disorder and suggested that linkage
of Paget at 18q21-q22 was relatively uncommon (Hock-
ing et al. 2000; Nance et al. 2000; Good et al. 2001).
Recently, the FEO disease gene has been identified as
the TNFRSF11A gene (MIM 603499) that encodes the
receptor activator of nuclear factor–kB (RANK) (Hughes
et al. 2000). The same heterozygotic insertion (84dup18)
was detected in exon 1 of TNFRSF11A in three families
with either FEO or FEO-related symptoms. One pedi-
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gree of Japanese origin that had atypical Paget disease of
bone also carried a 27-bp insertion (75dup27) in the
TNFRSF11A gene. Their uncommon symptoms included
early onset and dental problems, suggesting that these
patients may suffer from either a milder form of FEO or
a particular early-onset form of Paget disease of bone
(Leach et al. 2001). No RANK mutations have yet been
reported for patients manifesting typical symptoms of
Paget disease of bone (Hughes et al. 2000; Sparks et al.
2001).
To decipher the molecular basis of Paget disease of
bone, we conducted genetic-linkage and haplotype stud-
ies in French Canadian families. Kindreds originating
from this population are particularly well suited for
such studies (Morissette et al. 1995, 1998). Indeed, for
social and linguistic reasons, this population has main-
tained, for the past 3 centuries, a demographic growth
without immigration and, until recently, a high birth
rate with large sibships (i.e., 10–15 sibs/generation)
(Bouchard and Braekeleer 1991). Pedigree reconstruc-
tion is also facilitated by this population’s conservation
of genealogical records, including birth, marriage, and
death certificates that go back to the first immigrants.
To counteract the genetic heterogeneity of Paget disease
of bone, we exploited these attributes and undertook
the systematic screening of large French Canadian fam-
ilies affected by the disorder. A total of 554 members
of 24 families, each of which included at least two af-
fected members, were recruited. We report here both
the exclusion of the PDB2 locus as an important disease
locus in these families and the mapping, at 5q35-qter
and at 5q31, of two novel loci for Paget disease of bone.
Since one very large family showed LOD scores !2.00
at PDB2, 5q35-qter, and 5q31 and had !.01 conditional
probability of being linked to these two novel loci, our
data also suggest the presence of at least one additional
locus for Paget disease of bone and confirm its genetic
heterogeneity.
Patients, Material, and Methods
Clinical Investigation and Phenotypic Classification
This research has been approved by the Centre Hop-
sitalier de l’Universite´ Laval (CHUL) Research Center
Ethics Committee. All participants, affected or not,
signed an informed-consent document before entering
the study. Clinical assessment comprised complete bone
evaluation, including measurement of total serum al-
kaline phosphatase, skull and pelvis X-rays (enlarged
view including the last three lumbar vertebrae, the pelvis,
and the femoral heads), and total-body bone scan. Up
to 10% of adult and up to 20% of elderly patients with
symptomatic Paget disease of bone have levels of total
serum alkaline phosphatase that are within the labora-
tory reference range (Kanis 1998). The most common
sites for involvement are the pelvis, lumbar spine, and
proximal femur. Pelvis X-rays with enlarged view have
thus been associated with a sensitivity of 85% (Kanis
1998) to 91% (Re´nier et al. 1995) in detection of Paget
disease of bone. As a general rule, scintigraphy is more
sensitive than radiography, identifying 97%–98% of the
pagetic lesions (Meunier et al. 1987).
Criteria for diagnosis of Paget disease of bone were
abnormal-bone characteristics with monostotic or po-
lyostotic increased bone uptake associated with typi-
cal radiographic lesions in the affected sites. Individuals
140 years of age were considered normal when they
presented with normal bone scan, normal skull and pel-
vis X-rays, and normal levels of total serum alkaline
phosphatase. Subjects !40 years of age who had normal
levels of total serum alkaline phosphatase and/or normal
bone scan/X-rays were considered to be of unknown
status, as were all subjects for whom the data were in-
sufficient to establish a diagnosis.
Genealogical Procedures
Pedigree genealogies were reconstituted, after permis-
sion has been obtained from the families, on the basis
of registers compiled from Catholic parish records,
which systematically list births, marriages, and deaths
of 98% of the Que´bec population. Validations of the
family trees were obtained through interviews with key
family members. The Archives Nationales du Que´bec,
the Que´bec and the Que´bec Civil Register, were also
consulted. Most of the families came from the same re-
gion of the Province of Que´bec, ∼120 km from Que´bec
City.
Venipunctures and DNA Extraction
Two blood samples (10 ml each) were obtained by
venipuncture from consenting individuals. DNA was ex-
tracted from leukocytes by the guanidine hydrochlo-
ride–proteinase K method (Jeanpierre 1987). One ad-
ditional 10-ml blood sample was drawn from selected
subjects, to establish lymphoblastoid cell lines (Anderson
and Gusella 1984).
Chemiluminescent Genotyping at the PDB2 Locus
A total of 11 microsatellite markers at the PDB2 lo-
cus, which were selected from the Ge´ne´thon database
(Dib et al. 1996), were analyzed. Four markers were
tested within 19 families, whereas 11 microsatellites
were genotyped in kindreds DD and TH. Genotyping at
the PDB2 locus was done by a protocol similar to the
procedure reported by Vignal et al. (Vignal et al. 1993;
Morissette et al. 1995). In brief, PCR amplifications were
performed in a 50-ml reaction mixture containing 100
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ng of genomic DNA, 31.3 mM each dNTP, 10–50 pmol
of each primer, 1 # PCR buffer (50 mM KCl, 10 mM
Tris [pH 9.0], 1.5 mM MgCl2, 0.01% gelatine, and 0.1%
Triton X-100), and 1 U ofTaq polymerase (Perkin-Elmer
Cetus). Samples were processed through 35 cycles of
denaturation (95C at 30 s), annealing (55C at 30 s),
and extension (72C at 30 s). PCR products were diluted
with 95% formamide, 0.1% xylene cyanol, and 10 mM
NaOH and were resolved by electrophoresis on 6%
polyacrylamide gels. Samples were then transferred onto
Hybond N nylon membrane (Amersham), hybridized
with a (CA)20 oligomer 3
′-labeled with digoxigenin-11-
ddUTP, and detected by chemiluminescence using the
DIG system (Roche) with Kodak BioMax MR-1 film.
Genotypes were scored relative to reference alleles of
CEPH-family individual 134702. Inheritance of all al-
leles was verified by PedCheck (O’Connell and Weeks
1998). Genotyping was repeated on individuals pre-
senting with allele-size incompatibilities.
Automated Fluorescent Genomewide Scan
After exclusion of the PDB2 locus, a genomewide scan
was performed at the Centre National de Ge´notypage
(CNG) (Evry, France). Automated multiplex genotyping
was done by use of ABI PRISM Linkage Mapping Set
version 2, comprising 400 microsatellite markers spaced
at an average distance of 10 cM. Four primer sets were
usually amplified together, and PCR reactions were per-
formed as recommended by the manufacturer. PCR prod-
ucts were pooled and were separated on a 377ABI DNA
sequencer. Twenty-one markers that gave inconsistent re-
sults were removed from the study, leaving 379 micro-
satellites for statistical analyses. Almost all markers were
processed in combination panels; some of them were re-
peated singly. Raw genotypic data consisting of allele
sizes, estimated by GENOTYPER (ABI), were transferred
to the CHUL Research Center for data analysis.
Radioactive Genotyping for Linkage Confirmation and
Disease-Locus Refinement
To confirm and to refine the regions that stood out in
the genomewide scan, the three family nuclei selected
for the scan were extended, and additional pedigrees
were recruited, as described in the Results section (see
below). These individuals were genotyped with up to 90
additional markers, by a standard radioactive protocol.
In brief, markers were labelled by [35S]a-dATP incor-
poration in a 20-ml PCR reaction mixture containing 50
ng of genomic DNA; 1# PCR buffer; 0.2 mM each of
dCTP, dTTP, and dGTP; 10 mM dATP; 4–20 pmol of
each primer; and 1.5 mCi (1.5 pmol) [35S]a-dATP. PCR
conditions were 35 cycles of 95C at 30 s, 55–57C at
30 s, and 72C at 5–10 s. Samples were resolved by
electrophoresis on 6% polyacrylamide gels. The gels
were then exposed to X-ray film for 12–48 h.
Data Processing, Linkage Analysis, and Haplotype
Studies
Genotypic data and family information were stored
in a 4D database on a Macintosh G4 (Morissette 1992;
Morissette et al. 1995). Raw genotypic data obtained
from CNG were binned into odd or even values, ac-
cording to reference alleles from individual 134702, by
a data-import 4D script developed locally. Radioactive
and fluorescent genotyping data were merged together,
on the basis of reference alleles from individual 134702.
Data were transferred from the 4D database to SUN
computers by CAP AppleShare server software. Com-
putations were made on either a SUN Enterprise Ultra
30 or a SUN Enterprise 450. Parametric two-point LOD
scores were calculated by the MLINK program from the
LINKAGE package (FASTLINK 4.1P) (Lathrop and Lal-
ouel 1984; Scha¨ffer et al. 1994), with a disease-allele
frequency of .015 and an autosomal dominant model.
On the basis of pedigree and clinical information, we
defined five liability classes, with age-dependent pene-
trances of 0.1% (age !20 years), 10% (age 20–29 years),
10% (age 30–39 years), 50% (age 40–49 years), and
95% (age 50 years) and with phenocopy probabilities
of .001, .001, .005, .01, and .02, respectively. Multipoint
parametric linkage analyses and haplotyping studies
were done with SIMWALK 2.6 (Sobel and Lange 1996).
Because allele frequencies of the ABI markers used in
the genome scan had not been determined in the French
Canadian population and because the number of indi-
viduals genotyped was too small to allow accurate es-
timation, allele frequencies were assumed to be equal for
two-point linkage analyses in our genomewide scan.
This procedure may lead to spurious results (Freimer et
al. 1993). For locus confirmation and refinement, ac-
curate allele frequencies were therefore estimated by IL-
INK (VITESSE 2.0) (O’Connell and Weeks 1995), on
the basis of the genotypes obtained from all available
pedigrees (Boehnke 1991). The calculation of LOD
scores in the presence of heterogeneity was performed
by the HOMOG program (Ott 1991).
Results
Phenotypic and Segregation Studies
We recruited 24 French Canadian families, each with
at least two affected first-degree relatives, comprising a
total of 554 individuals, including 56 spouses. These
kindreds were of different sizes and complexities. Eight
of them comprised 30–71 individuals, and 14 displayed
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Table 2
Summed Two-Point LOD-Scores for Markers Spanning the PDB2 Locus at Chromosome 18q21-q22
MARKER (LOCUS)
LOD SCORE AT v p
DISTANCE
(cM)
NO. OF
FAMILIES.0 .01 .05 .1 .2 .3 .4
AFM212xg5 (D18S64) 6.41 5.73 3.87 2.36 .73 .12 .00 3.6 19
AFMb330zc5 (D18S1134) 5.27 4.74 3.28 2.13 .83 .24 .03 2.2 7
AFMa052va9 (D18S1148) 1.36 1.30 1.10 .82 .34 .08 .00 .0 14
AFMa049ze5 (D18S1147) 10.25 9.14 6.49 4.38 1.91 .64 .14 6.5 18
AFM248yb9 (D18S68) 7.54 6.41 3.96 2.34 .82 .28 .06 .1 8
AFM122xc1 (D18S55) 4.61 4.22 3.15 2.20 .92 .26 .03 … 14
Paget disease of bone in two generations. Twelve pedi-
grees came from the same geographic area.
Of these 554 individuals, 105 were diagnosed with
Paget disease of bone, 303 were classified as normal,
and 146 were classified as unknown, according to our
classification procedure. Age at diagnosis was 29–89
years, with a mean age of 58 years. The majority (63/
105 [60%]) of these patients were diagnosed at 60
years of age, whereas only a small number (3/105
[2.9%]) were diagnosed at !40 years of age, confirming
that the penetrance of the disease was highly age de-
pendent. Sex distribution of the 105 patients showed an
equal number of females (53) and males (52), and at
least nine kindreds displayed male-to-male transmission,
thus excluding X-linked dominant transmission. Among
the 97 subjects 140 years of age who had one affected
parent, the classifications were as follows: 35 with Paget
disease of bone, 40 normal, and 22 unknown. Our ob-
servations therefore strongly suggest that, within the
pedigrees that we studied, Paget disease of bone is seg-
regating as an autosomal dominant trait with an incom-
plete age-dependent penetrance.
Table 1 lists the clinical characteristics of represen-
tative affected individuals selected for the genomewide
scan. Four members in family LF were diagnosed with
a benign autosomal dominant form of adult osteope-
trosis; two of them showed concomitant Paget disease
of bone.
Exclusion of the PDB2 Locus at 18q21-q22
Linkage to the PDB2 locus was tested by genotyping
six Ge´ne´thon markers spanning 11.5 cM at chromosome
18q21-q22: AFM212xg5 (D18S64), AFMb330zc5
(D18S1134), AFMa052va9 (D18S1148), AFMa049ze5
(D18S1147), AFM248yb9 (D18S68), and AFM122xc1
(D18S55). At least four of these markers were assessed
in each of the 19 largest pedigrees, in a total of 343
individuals. Table 2 shows that five of the microsatellites
displayed LOD scores !4.0 at recombination fraction
(v) .01. Only one of them, AFMa052va9 (D18S1148),
gave a LOD score 12.00 at all v values tested. Two
large pedigrees, DD and TH, were further genotyped
with seven additional markers to cover a 50-cM inter-
val at 18q: AFMa074yd9 (D18S1157), AFM295xh1
(D18S474), AFM057xb4 (D18S1127), AFMb317zc1
(D18S1129), AFM260yh1 (D18S465), AFM193yf8
(D18S61), and AFMa085yf1 (D18S1161). For nine
markers, LOD scores !1.00 were obtained at vp
, and only one marker, AFMA052va9 (D18S1148),.05
showed an isolated positive LOD score, 0.41 at vp
(data not shown). No characteristic haplotype seg-.00
regating with the disease was identified in any of the 19
families. These data therefore excluded, in a major pro-
portion of the population that we studied, the PDB2
region as a locus for Paget disease of bone.
Genomewide Scan
To define the genetic basis of Paget disease of bone
within the population that we studied, we performed a
genomewide scan after selecting the three most infor-
mative family nuclei. As depicted in figures 1 and 2, these
three family nuclei belonged to the much larger kindreds,
DD, TH, and LF. They represented a total of 44 indi-
viduals, all 140 years of age. In these kindreds, 18 per-
sons had been diagnosed with Paget disease of bone, 18
others were normal, and 5 were classified as unknown.
Within the family-LF nucleus, two pagetic patients se-
lected for our genome scan, LF-010 and LF-011, also
displayed a benign adult form of osteopetrosis. These
two individuals were considered to be affected. A third
person, LF-070, with osteopetrosis only, was classified
as unknown, since any association between Paget disease
and osteopetrosis remains elusive. To estimate the ex-
pected average LOD score of our sample, we used
SLINK. In case of homogeneity, if all three family nuclei
were linked to the same locus, we estimated an average
LOD score of 2.2 for a six-allele marker system at 5 cM
of the disease gene. In case of heterogeneity, the expected
average LOD score for each individual family would be
0.70 at .vp .05
Genotypes of 379 microsatellite markers covering the
whole genome, at an average spacing of 11.5 cM, were
analyzed in these 44 individuals. As depicted in figure
3, two-point LOD scores were plotted versus map dis-
tance, for all chromosomes. No evidence for linkage was
obtained at the PDB1 locus, with LOD scores !0.26 for
Figure 1 Pedigree structure and haplotypes of the extended pagetic families DD and TH, showing linkage to chromosome 5q35-qter. Individuals selected for the genomewide scan are indicated
by an asterisk (*). Circles and squares represent females and males, respectively; blackened symbols denote individuals affected by Paget disease of bone; empty white symbols denote individuals
whose status is unknown or for whom the data were insufficient for phenotypic classification; an “N” within a white symbol denotes that the individual is normal; a question mark (?) within a white
symbol denotes that the diagnosis is ambiguous; and a diagonal line through a symbol denotes that the individual is deceased. The number in parentheses below each symbol denotes the individual’s
age at the time of the study. “D5S” numbers for each marker genotyped are shown on the left of the third generation of each pedigree; refinement of the disease locus is shown on the left of these
“D5S” numbers. The disease-associated haplotypes are denoted by the vertical black bars; within the haplotypes, maternal crossover is denoted by a slash (/), paternal crossover by a back slash (\).
Figure 2 Pedigree structure and haplotypes spanning the 5q31 region in extended family LF. Blackened symbols with a white lower-left corner denote individuals diagnosed with concomitant
Paget disease of bone and benign osteopetrosis; tiled symbols denote individuals diagnosed with osteopetrosis only; arrows (r) indicate key recombinant events; all other symbols are as described in
figure 1. A spontaneous mutation was detected in marker AFM263wg5 (D5S436) in individual LF-045 and is enclosed within parentheses.
Laurin et al.: Mapping of Two PDB Loci at 5q35-qter and 5q31 535
Table 3
HOMOG Analysis for Markers Spanning the 5q35-qter Region in
24 French Canadian Families
MARKER (LOCUS)
MAXIMUM
LOD SCORE (vmax)
a x2Homogeneity Heterogeneity
AFM238xe11 (D5S498) 3.27 (.2) 4.07 (.08) .54 3.70a
AFMb307za9 (D5S2030) .62 (.28) 1.05 (.12) .28 2.01
AFM323yh1 (D5S2073) 7.98 (.16) 8.58 (.10) .64 2.77
AFM164xb8 (D5S408) 3.82 (.20) 4.66 (.00) .35 3.86a
AFMb005wf9 (D5S2006) 3.44 (.22) 3.64 (.16) .59 .91
a Significant evidence for heterogeneity, at .P ! .05
Figure 3 Summary of genomewide scan for susceptibility loci for Paget disease of bone, in three French Canadian family nuclei. Two-
point LOD scores are shown, and markers with LOD scores 11.0 are indicated. Gray vertical lines denote chromosome boundaries.
markers spanning the whole chromosome 6, suggesting
that none of the three family nuclei had linkage to this
locus.
The maximum two-point LOD score detected by our
genomewide scan was at chromosome 19q—a value
of 2.79 for AFM295xg9 (D19S414) at . Posi-vp .00
tive LOD scores were observed over a 54-cM interval
between AFM295xg9 (D19S414) and AFM347ze1
(D19S571). To better assess these linkage results, all
available members from the three extended families
(139 individuals) were then genotyped with four mi-
crosatellites covering the interval of positive values;
AFMa058xc5 (D19S931), AFM295xg9 (D19S414),
AFM248zc1 (D19S225), and AFMa154xg1 (D19S868).
After these procedures, the LOD score for AFM295xg9
(D19S414) decreased to 0.11 at , for the threevp .00
extended pedigrees (data not shown). When families
were analyzed individually, only pedigree TH continued
to have a positive LOD score, 0.96 at forvp .01
AFM295xg9 (D19S414) (data not shown). However,
haplotype studies within this kindred demonstrated that
only seven of the nine pagetic subjects shared the same
haplotype. To further test this region, we genotyped 19
additional families (343 individuals), using the same four
markers. Summed LOD scores were !2.00 at vp
, for all markers (data not shown). No haplotype was.00
shared between the affected individuals within these kin-
dreds. These investigations therefore did not support the
presence, within the vicinity of AFM295xg9 (D19S414)
in the French Canadian population, of a major locus for
Paget disease of bone.
Mapping and Refinement of a PDB Locus at 5q35-qter
In addition to chromosome 19, LOD scores 11.0 were
observed at chromosomes 1p, 3p, 4q, 5q, 13q, and 15q
(fig. 3). To evaluate presence of linkage within these
regions, the large extended pedigrees DD, TH, and LF
were genotyped with additional markers covering these
areas. Linkage and haplotype analyses led to exclusion
of chromosomes 1p, 3p, and 15q (data not shown). As
regards chromosome 5q, two additional markers—
AFM238xe11 (D5S498) and AFM323yh1 (D5S2073)—
were genotyped, in order to cover a 19-cM gap, pres-
ent in the ABI version 2 panel, between AFM112yb6
(D5S400) and AFM164xb8 (D5S408). Interestingly, after
examination of the distribution of the alleles, a common
haplotype segregating with the disorder was detected in
all affected members of families DD and TH. Genealogical
studies further revealed that these two kindreds shared
several founders. These observations led us to thoroughly
test for linkage to chromosome 5q35.
To confirm linkage between 5q35 and Paget disease of
bone, all available members of families DD and TH (i.e.,
81 individuals) were genotyped for the region between
AFM324yf9 (D5S2075) and AFMb005wf9 (D5S2006),
with 13 markers spaced at an average distance of 1.5
cM. A maximum LOD score of 5.88 was observed at
, for AFM238xe11 (D5S498), in the extendedvp .05
families DD and TH (data not shown). All affected sub-
jects shared one characteristic haplotype comprising
four markers between AFM323yh1 (D5S2073) and
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Table 4
Haplotypes of Eight Families Showing Linkage to the 5q35-qter Region
MARKER (LOCUS)a
DISTANCE
(cM)
HAPLOTYPE OF FAMILYb
TH* NA* MA* GA* BT DA LG DD*
AFM324yf9 (D5S2075) 2.1 4 4 2 5 … … … 1
AFM210vf12 (D5S625) 2.2 5 2 2 1 … … … 1
AFM242xb10 (D5S429) 3.3 12 2 1 4 … … … 1
AFM350xh1 (D5S677) 2.3 1 1 1 1 … … … 3
AFM238xe11 (D5S498) 3.2 2 2 2 2 4 6 5 2
AFMa083wc5 (D5S2111) 1.9 2 2 2 2 2 2 2 4
AFMb010wa5 (D5S2008) 1.1 1 1 1 1 1 1 1 3
AFMb307za9 (D5S2030) .7 2 2 2 2 2 2 2 1
AFM137xf6 (D5S469) 3.4c 2 2 2 2 2 2 2 1
AFM323yh1 (D5S2073) .8 12 12 12 12 12 12 12 12
UT6507 … 3 3 3 3 3 3 3 3
AFM164xb8 (D5S408) 1.8 3 3 3 3 3 3 3 3
AFMb005wf9 (D5S2006) … 2 2 2 2 2 2 2 2
a “AFM” markers are in the order reported in the Ge´ne´thon database (Dib et al. 1996); UT6507 is
mapped relative to the chromosome 5 physical map of the Human Genome Project (National Center for
Biotechnology Information).
b Asterisks (*) indicate families that are known to share founders. The shared disease haplotype is
boxed.
c Estimated on the basis of all genotyped families, by ILINK (Scha¨ffer et al. 1994).
AFMb005wf9 (D5S2006), a region that covered 6 cM
(fig. 1). To fully assess this region, we then genotyped the
21 other families. Table 3 presents the combined linkage
analysis of the 24 pedigrees, for five markers spanning
this region. A maximum two-point LOD score of 7.98
was obtained, for AFM323yh1 (D5S2073) at .vp .16
Genotype analysis revealed that affected members of
six additional families carried a haplotype identical to
that identified between AFM238xe11 (D5S498) and
AFMb005wf9 (D5S2006) in family TH (table 4).
Therefore, of the 24 families, 8 harbored a unique dis-
ease haplotype between AFM137xf6 (D5S469) and
AFMb005wf9 (D5S2006), and common ancestors were
found in 5 of these 8 families. Penetrance rates of the
disease were estimated in 101 carriers in these 8 kindreds.
Of the 26 carriers !50 years of age, only 5 manifested
Paget disease of bone, for a penetrance rate of 19%.
Among the 28 carriers 50–59 years of age, 13 were di-
agnosed as affected, for a penetrance rate of 46%,
whereas, among the 40 carriers60 years of age, 31 were
affected, for a penetrance rate of 78%; in this last age
group, 6 carriers 170 years of age were asymptomatic.
When calculated independently, LOD scores for kin-
dred LF were between 2.54 and 4.38, for markers
between AFM238xe11 (D5S498) and AFMb005wf9
(D5S2006), at 5q35. Furthermore, two other families also
showed negative LOD scores, !2.00, for these markers.
These observations prompted us to test, at this locus
within our set of 24 families, genetic heterogeneity of
Paget disease of bone, using the HOMOG program. As
depicted in table 3, significant evidence for heterogeneity
( ) was observed at AFM238xe11 (D5S498)P ! .05
( ) and AFM164xb8 (D5S408) ( ). In-2 2x p 3.70 x p 3.86
deed, when heterogeneity was allowed, a maximum two-
point LOD score of 4.66 was obtained at , forvp .00
AFM164xb8 (D5S408), when only a fraction ( )ap .35
of the families were assumed to show linkage to the dis-
ease locus. Interestingly, this estimated a value of 35%
was very similar to the ratio of families (8/24 [33.3%])
carrying the common disease haplotype. To better posi-
tion the disease gene, multipoint parametric LOD scores
were then calculated for the eight families that harbored
the common haplotype, by use of the corresponding age-
dependent penetrance rates, as determined above. This
multipoint analysis showed a plateau with a LOD score
of 11.5, between AFMb307za9 (D5S2030) and
AFMb005wf9 (D5S2006), and demonstrated a maxi-
mum location score of 11.8 at AFM323yh1 (D5S2073)
(fig. 4). The plateau covered a 6-cM interval that corre-
sponded to the smallest region cosegregating with the
Paget-disease-of-bone phenotype observed in family DD
(fig. 1 and table 4).
Mapping and Refinement of a Second PDB Locus at
5q31
The disease haplotype shared at 5q35-qter by affected
members of the 8 families was not found in the 16 other
kindreds, including family LF. Moreover, the HOMOG
test performed on marker AFM164xb8 (D5S408) esti-
mated that the conditional probability that three of the
families would show linkage to this region was !.01, sug-
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Figure 4 Multipoint parametric LOD scores at 5q35-qter in
eight families showing linkage. The phenotypic model was modified
according to penetrance values estimated on the basis of 101 individ-
uals who carry the disease haplotype. Allele frequencies were estimated
on the basis of all genotyped pedigrees, according to Boehnke’s (1991)
method. Genetic distances are from genetic maps reported elsewhere
(Dib et al. 1996)—except for UT6507, which was mapped relative to
other markers by use of Human Genome Project (National Center for
Biotechnology Information) draft sequences.
gesting the presence, within the population that we stud-
ied, of at least one additional disease-gene locus for Paget
disease of bone (table 3). To identify this region, the ge-
nome-scan data were reanalyzed with use of only the
results obtained with the family-LF nucleus. The highest
LOD score obtained for the family-LF nucleus was 1.95
at , for AFM263wg5 (D5S436). After additionalvp .00
members of the family were studied and additional mark-
ers were genotyped, maximum LOD scores of 2.98–
2.94 were obtained at loci AFMa102zg1 (D5S2117),
AFM042xd12 (D5S393), AFM240xg3 (D5S500),
AFM203ye7 (D5S2010), and AFMb074xg1 (D5S2017),
at (data not shown). As depicted in figure 2, avp .00
common haplotype was shared by all pagetic individuals
in the pedigree. We then genotyped the 15 other fami-
lies, which did not harbor the 5q35-qter disease haplo-
type, using five markers spanning 9 cM at 5q31:
AFM042xd12 (D5S393), AFM240xg3 (D5S500),
AFMb074xg1 (D5S2017), AFM263wg5 (D5S436), and
AFMa052th5 (D5S2090). A LOD score of 3.70 was ob-
tained for AFM240xg3 (D5S500), at , with al-vp .00
lowance for heterogeneity (table 5). Indeed, significant
evidence for heterogeneity was obtained for three of the
five markers, with a values of .28–.38 (table 5). These
results gave evidence of a second disease locus, at 5q31.
For three markers tested at 5q31 in families LF and FT,
the HOMOG conditional probability for linkage was
1.99 . The maximum LOD score for family FT was 2.32
at , for both AFM203ye7 (D5S2010) andvp .00
AFMa102zg1 (D5S2170) (data not shown). Genotype
analysis further showed a common haplotype shared by
all affected members of family FT (fig. 5). This char-
acteristic haplotype was, however, different from the dis-
ease haplotype segregating within family LF.
To refine the 5q31 disease interval, families LF and
FT were genotyped with a total of 18 markers (figs. 2
and 5). In family LF, a centromeric recombination event
was observed in affected individual LF-074, between
AFMb355wf5 (D5S2055) and AFM144yf4 (D5S404).
In this kindred, the most telomeric recombination event
occurred in affected individual LF-045, between
AFMa190xb1 (D5S1972) and AFM282wd5 (D5S638).
This interval corresponded to a 21-cM region at chro-
mosome 5q31. In family FT, a recombination event
in affected subject FT-028 delimited the centromer-
ic boundary of the disease locus, at AFM286xg9
(D5S642). In recombinant FT-007, the telomeric bound-
ary was at AFM263wg5 (D5S436). These four recom-
bination events confined the 5q31 disease locus within
a 12.2-cM interval delineated by markers AFM286xg9
(D5S642) and AFMb074xg1 (D5S2017).
Because the 5q31 disease region was 30 cM distant
from our first localization at 5q35-qter, and because
these two intervals were delimited by specific recombi-
nation events, we concluded that these two loci harbored
two distinct disease genes. We suggest the acronyms
“PDB3” and “PDB4” as names for the 5q35-qter and
5q31 loci, respectively.
Discussion
This study led to several important findings. We first
reported a collection of large families in which Paget
disease of bone was segregating as an autosomal dom-
inant trait. We next excluded PDB2, at 18q21-q22, as
a major locus for the disorder in these families. Com-
pletion of a genomewide scan, study of additional family
members, and higher-density genotyping within regions
of interest led to the mapping of two novel loci for Paget
disease of bone, at 5q35-qter and 5q31. Key recombi-
nants were then exploited to confine the 5q35-qter locus
within a 6-cM interval, whereas the 5q31 locus was
refined within 12.2 cM. Observation of a large family
with LOD scores !2.00 at PDB2, 5q35-qter, and 5q31
suggested the existence of at least one additional locus
for Paget disease of bone, confirming genetic heteroge-
neity of the disorder.
PDB1 and PDB2 were excluded in three family nuclei
and in 19 of the kindreds, respectively. We thus inferred
that these two loci may play only a minor role, if any,
in Paget disease of the bone in the French Canadian
population. Since only one previously published report
has shown suggestive evidence for linkage to PDB1 (Fo-
tino et al. 1977), more investigations are required to
confirm presence of a disease gene at 6p. On the other
hand, six families have been reported to show linkage
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Table 5
HOMOG Analysis for Markers Spanning the 5q31 Region after Removal of Eight Families
Showing Linkage to 5q35-qter
MARKER (LOCUS)
MAXIMUM LOD SCORE (vmax)
a x2 PHomogeneity Heterogeneity
AFM042xd12 (D5S393) 1.73 (.22) 3.64 (.00) .34 8.76a .002
AFM240xg3 (D5S500) 1.50 (.24) 3.70 (.00) .38 10.13a .0001
AFMb074xg1 (D5S2017) 1.75 (.22) 3.43 (.00) .28 7.73a .003
AFM263wg5 (D5S436) 1.02 (.26) 2.09 (.04) .35 4.92 .015
AFMa052th5 (D5S2090) .52 (.26) .55 (.16) .44 .14 …
a Significant evidence for heterogeneity.
to PDB2 (Cody et al. 1997; Haslam et al. 1998). It is
not yet known, however, whether any of these kindreds
harbor mutations either in the FEO disease gene,
TNFRS11A, or in a second gene within its vicinity.
Our preliminary genome-scan analysis revealed seven
regions with LOD scores 11.0 (fig. 3). The highest value
(2.79) was reached with AFM295xg9 (D19S414), at
chromosome 19q. Further analysis of this region, with
additional markers and individuals, revealed that this
peak represented, in fact, a false-positive linkage result.
Similar procedures also led to marked decreases of LOD
scores at chromosomes 1p, 3p, and 15q. These false-
positive results were caused mainly by genetic hetero-
geneity of the disorder within the three family nuclei
selected for the genomewide scan, in which the initial,
relatively small per-locus number of individuals showing
linkage reduced the specificity of the linkage test. If all
three family nuclei showed linkage to the same locus,
then linkage to 5q35-qter would have been easier to de-
tect; on the other hand, we would have missed the 5q31
locus. Two other factors also markedly influenced LOD
scores obtained during our genomewide scan. These fac-
tors were marker informativity and genetic distances be-
tween markers composing the ABI panel. As mentioned
above (see the “Mapping and Refinement of a PDB locus
at 5q35-qter” subsection), a 19-cM gap located between
AFM112yb6 (D5S400) and AFM164xb8 (D5S408)
made it more difficult to detect linkage to 5q35. Phe-
notypic characterization also played a major role in the
linkage analysis. A complete reevaluation of all diag-
nosis was therefore performed in a blind fashion before
final analysis of our data. These four factors (small num-
ber of individuals, marker informativity, marker dis-
tance, and phenotypic characteristics) hindered identi-
fication of the disease loci during the first pass of our
genomewide scan, and therefore only suggestive evi-
dence for linkage was observed. Nevertheless, the large
size of several of the pedigrees collected, often com-
prising more than 30 individuals, and the presence of
founder effects in many of the families that we studied
counteracted these pitfalls. In the end, these two major
features allowed us to obtain convincing evidence for
linkage to the disease loci, even if Paget disease of bone
is a genetically heterogeneous disorder within the pop-
ulation that we studied.
Genetic heterogeneity of Paget disease of bone within
our set of families was first suggested by exclusion, at
5q35-qter, of kindred LF. This hypothesis was subse-
quently confirmed by our HOMOG analysis of the 24
families. When this test was first applied to the five mi-
crosatellites genotyped at 5q35 in all families, it was sig-
nificant for only two markers. This lack of significance
for the three other markers may be explained by the low
power of HOMOG to detect heterogeneity when .v 1 .1
Using 20 families, for which a, the proportion of families
showing linkage to a simulated locus, was 30% (i.e.,
), Ott (1986) demonstrated that the probabilityap .30
to detect genetic heterogeneity with HOMOG decreased
from .898 at to .54 at . In agreementvp .01 vp .10
with this study, only the two 5q35 markers—
AFM164xb8 (D5S408) and AFM238xe11 (D5S498)—
showing a maximum v (vmax) !.1 gave significant x
2
values. All 5q31 microsatellite markers that showed
also gave significant x2 values.v p 0max
The estimation of genetic heterogeneity is important
in the attempt to determine whether a corresponds ex-
actly to the ratio really observed. However, estimation
of v and a by the HOMOG test is subject to several
biases (Janssen et al. 1997). These biases include pref-
erential extension of families already showing linkage
to one locus, as well as misclassification and/or diag-
nostic errors. In our study, ascertainment biases were
minimized because family recruitment was completed
before the genotyping process was begun. Moreover,
diagnoses of all members of the three family nuclei used
in our genome scan were carefully revalidated. Disease-
gene expressivity and its related penetrance may also
introduce biases, if these two parameters vary between
the different disease loci. In this regard, we have no
evidence that age-dependent penetrance ratios of the
disorder differed between the families showing linkage
to the two loci. Finally, precise estimates of v and a are
obtained only when the sizes of families showing linkage
are similar to those of families not showing linkage.
Figure 5 Pedigree structure and haplotypes spanning the 5q31 region in extended family FT. Symbols are as described in figures 1 and 2.
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Since several families in our study were small, linkage
cannot be conclusively established for each one of them.
Nevertheless, the ratio of pedigrees showing linkage at
AFM164xb8 that were estimated by HOMOG was
35%, a percentage very similar to the proportion of
families harboring the common disease haplotype at
5q35-qter (8/24 [33.3%]). When HOMOG was applied
at 5q31 in the 16 other families, the test showed evi-
dence for linkage, under heterogeneity, for three mark-
ers spanning this interval, and the estimated proportion
of families showing linkage was 28%–38%. Two large
families, LF and FT, showed linkage, at a high level of
confidence, to the 5q31 locus, whereas linkage to this
region was excluded in one other large pedigree. On the
other hand, of the 13 remaining families, several were
small and could not be demonstrated to show linkage
individually at either locus; none of them harbored one
of the three identified disease haplotypes. Finally, since,
in the very large family, linkage to 5q35-qter and PDB2,
as well as to 5q31, was excluded, at least one additional
locus for Paget disease of bone remains to be mapped.
Such high genetic heterogeneity, with, potentially, five
disease-gene loci, may explain the large prevalence of
Paget disease of bone in the general population.
Using a relatively homogeneous population, we ex-
pected to observe at least one founder effect, particu-
larly if, in the population that we studied, the trait locus
was controlled by a few major genes. In agreement with
this assumption, we detected a common, 6-cM disease
haplotype at chromosome 5q35-qter, in all affected in-
dividuals in eight of the pedigrees that we studied. In
contrast to this observation, the two pedigrees showing
linkage to 5q31 did not harbor the same disease hap-
lotype, and, as far as we know, they do not share com-
mon ancestors. Thus, Paget disease of bone in these two
families showing linkage to 5q31 may be caused by two
different mutations either in the same gene or in two
closely linked genes. Alternatively, these two families
may share a common haplotype shorter than the dis-
tance between two of the markers genotyped in this
study. Genotyping more markers within the linkage in-
terval will help to prove this hypothesis.
One important phenotypic observation in this study
was the concomitant diagnosis of both Paget disease of
bone and benign osteopetrosis in two individuals in
family LF (fig. 2). To our knowledge, this is the first
time that these two diseases have been diagnosed within
the same individual. Osteopetrosis mutations generally
involve an absence or a decrease of osteoclastic func-
tions, whereas osteoclasts in Paget disease of bone are
overactive and each phase of the bone-remodeling pro-
cess is accelerated. The presence of both disorders in
the same person may thus appear to be contradictory,
since their concomitant expression may involve poten-
tially antagonistic mechanisms. All four osteopetrotic
patients in family LF harbored the Paget-disease-of-
bone haplotype, suggesting that both of these diseases
may be linked to 5q31, either involving closely linked
genes or being caused by the same mutation but leading
to different phenotypes. Association of benign osteo-
petrosis with Paget disease of bone may also have oc-
curred by chance, since this association was observed
in only two patients. At present, it is difficult to assess
whether both disorders are associated, with benign os-
teopetrosis preceding the development of Paget disease
of bone, since phenotypic manifestations of osteope-
trosis are usually detected in younger individuals,
whereas Paget disease of bone is rarely diagnosed at
!40 years of age.
This study has emphasized the importance of heredity
in the pathogenesis of Paget disease of bone and has
confirmed the dominant-segregation model originally
proposed by McKusick (1972). However, penetrance of
the disease within the families that showed linkage was
lower than that expected at the beginning of our in-
vestigations and was highly age dependent. Penetrance
frequencies observed here may not be applicable to
other studies of linkage of Paget disease of bone, since
the genetic defects involved in the French Canadian fam-
ilies that we studied may alter disease expressivity.
Although the etiology of Paget disease of bone remains
unknown, it is likely that cytokine dysregulation may be
involved in its pathogenesis. Linkage of Paget disease of
bone to 5q31 is thus of particular interest, in light of the
fact that many of genes located within this chromosomal
segment are members of the cytokine family, including
those encoding interleukin-3, -4, -5, -9, and -13; colony-
stimulating factor–2; fibroblast growth factor–1; and
CD14; on the other hand, no gene seems to encode os-
teoclast- or bone-specific protein in the 5q35-qter region.
In conclusion, we have reported the mapping and
refinement of two novel loci for Paget disease of bone;
the first locus was localized at 5q35-qter, the second at
5q31. We also have confirmed the genetic heterogeneity
of the disorder. Further work will be necessary to iden-
tify the causative genes and to elucidate the mechanisms
by which they contribute to the susceptibility of this
highly prevalent disorder.
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